Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis

The pathogenesis of SARS-CoV-2 remains to be completely understood, and detailed SARS-CoV-2 cellular cytopathic effects requires definition. We performed a comparative ultrastructural study of SARS-CoV-1 and SARS-CoV-2 infection in Vero E6 cells and in lungs from deceased COVID-19 patients. SARS-CoV...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cell death & disease Ročník 12; číslo 3; s. 263 - 12
Hlavní autoři: Nardacci, Roberta, Colavita, Francesca, Castilletti, Concetta, Lapa, Daniele, Matusali, Giulia, Meschi, Silvia, Del Nonno, Franca, Colombo, Daniele, Capobianchi, Maria Rosaria, Zumla, Alimuddin, Ippolito, Giuseppe, Piacentini, Mauro, Falasca, Laura
Médium: Journal Article
Jazyk:angličtina
Vydáno: London Nature Publishing Group UK 12.03.2021
Springer Nature B.V
Nature Publishing Group
Témata:
ISSN:2041-4889, 2041-4889
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The pathogenesis of SARS-CoV-2 remains to be completely understood, and detailed SARS-CoV-2 cellular cytopathic effects requires definition. We performed a comparative ultrastructural study of SARS-CoV-1 and SARS-CoV-2 infection in Vero E6 cells and in lungs from deceased COVID-19 patients. SARS-CoV-2 induces rapid death associated with profound ultrastructural changes in Vero cells. Type II pneumocytes in lung tissue showed prominent altered features with numerous vacuoles and swollen mitochondria with presence of abundant lipid droplets. The accumulation of lipids was the most striking finding we observed in SARS-CoV-2 infected cells, both in vitro and in the lungs of patients, suggesting that lipids can be involved in SARS-CoV-2 pathogenesis. Considering that in most cases, COVID-19 patients show alteration of blood cholesterol and lipoprotein homeostasis, our findings highlight a peculiar important topic that can suggest new approaches for pharmacological treatment to contrast the pathogenicity of SARS-CoV-2.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2041-4889
2041-4889
DOI:10.1038/s41419-021-03527-9